NAMPT inhibitors have emerged as promising drug candidates to block cancer cell proliferation and induce apoptosis, however, alike HDAC inhibitors, they are hampered by dose-limiting toxicities when used in isolation without drug combinations [96]. This evidence concerns the gene HDAC9 and cancer.